Junghyun Kim

Junghyun Kim

Auto-generated profile, based on publicly available information

Junghyun Kim

Center for Quantum Materials, Seoul National University, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2022 in npj Quantum Materials
Verified
Journal Article
Open access
PDF file
PPPyeongjae Park
Pyeongjae Park
YKYoon-Gu Kang
Yoon-Gu Kang
JKJunghyun Kim
Junghyun Kim
KLKi Hoon Lee
Ki Hoon Lee
HNHan-Jin Noh
Han-Jin Noh
JPJe-Geun Park
Je-Geun Park
Combining magnetism with band topology provides various novel phases that are otherwise impossible. Among several cases, noncollinear metallic antiferromagnets can reveal particularly rich topological physics due to their diverse magnetic ground states. However, there are only a few experimental studies due to the lack of suitable materials, especially with triangular lattice antiferromagnets. Here, we report that metallic triangular antiferromagnet Co1/3TaS2 exhibits a substantial anomalous Hall effect (AHE) related to its noncollinear magnetic order. Our first-principles calculations found that hourglass Weyl fermions from the non-symmorphic symmetry trigger AHE. We further show that AHE in Co1/3TaS2 can be characterized by the toroidal moment, a vortex-like multipole component that arises from a combination of chiral lattice and geometrical frustration. Finally, the unusual field-tunability of the toroidal moment puts Co1/3TaS2 as a rare example of a noncollinear metallic antiferromagnet filled with interesting magnetic and topological properties.

1 January 2017 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
SDSean P. Delaney
Sean P. Delaney
MNMatthew J. Nethercott
Matthew J. Nethercott
CMChristopher J. Mays
Christopher J. Mays
NWNickolas T. Winquist
Nickolas T. Winquist
DADonia Arthur
Donia Arthur
EMEric J. Munson
Eric J. Munson

27 July 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AWAnne E. Wyman
Anne E. Wyman
Trang NguyenTrang Nguyen
Trang Nguyen
PKPratap Karki
Pratap Karki
MTMohan E. Tulapurkar
Mohan E. Tulapurkar
CZChen-Ou Zhang
Chen-Ou Zhang
Konstantin G BirukovKonstantin G Birukov
Konstantin G Birukov
Acute lung injury (ALI), a common condition in critically ill patients, has limited treatments and high mortality. Aging is a risk factor for ALI. Sirtuins (SIRTs), central regulators of the aging process, decrease during normal aging and in aging-related diseases. We recently showed decreased SIRT7 expression in lung tissues and fibroblasts from patients with pulmonary fibrosis compared to controls. To gain insight into aging-related mechanisms in ALI, we investigated the effects of SIRT7 depletion on lipopolysaccharide (LPS)-induced inflammatory responses and endothelial barrier permeability in human primary pulmonary endothelial cells. Silencing SIRT7 in pulmonary artery or microvascular endothelial cells attenuated LPS-induced increases in ICAM1, VCAM1, IL8, and IL6 and induced endomesenchymal transition (EndoMT) with decreases in VE-Cadherin and PECAM1 and increases in collagen, alpha-smooth muscle actin, TGFβ receptor 1, and the transcription factor Snail. Loss of endothelial adhesion molecules was accompanied by increased F-actin stress fibers and increased endothelial barrier permeability. Together, these results show that an aging phenotype induced by SIRT7 deficiency promotes EndoMT with impaired inflammatory responses and dysfunction of the lung vascular barrier.

16 December 2019 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
KKKyoung-Ran Kim
Kyoung-Ran Kim
HJHyun Jegal
Hyun Jegal
JKJunghyun Kim
Junghyun Kim
DADae-Ro Ahn
Dae-Ro Ahn
While siRNA is a potent therapeutic tool that can silence disease-causing mRNA, its in vivo potency can be compromised due to the lack of target tissue specificity. Here, we report a wireframe tetrahedral DNA nanostructure having a 20-mer duplex on each side that can be specifically distributed into the liver upon systemic administration. This liver-targeted DNA tetrahedron is employed as the carrier for liver-specific delivery of siRNA targeting ApoB1 mRNA, which is overexpressed in hypercholesterolemia. When delivered by a DNA tetrahedron, the siRNA can preferentially be accumulated in the liver and down-regulate the ApoB1 protein. As a result, the blood cholesterol level is also decreased by the siRNA. These results successfully demonstrate that the DNA tetrahedron is a promising carrier for liver-targeted delivery of therapeutic nucleic acids.

1 June 2020 in Journal of Controlled Release
Verified
Journal Article
Closed access
JKJunghyun Kim
Junghyun Kim
SJSeulgi Jeon
Seulgi Jeon
SKSeong Jae Kang
Seong Jae Kang
KKKyoung-Ran Kim
Kyoung-Ran Kim
HTHien Bao Dieu Thai
Hien Bao Dieu Thai
DADae-Ro Ahn
Dae-Ro Ahn

1 November 2018 in Cancer Research
Verified
Journal Article
Open access
PDF file
HLHee-Sheung Lee
Hee-Sheung Lee
MCMar Carmena
Mar Carmena
MLMikhail Liskovykh
Mikhail Liskovykh
EPEmma Peat
Emma Peat
JKJung-Hyun Kim
Jung-Hyun Kim
Natalay KouprinaNatalay Kouprina
Natalay Kouprina
The targeting of telomerase and telomere maintenance mechanisms represents a promising therapeutic approach for various types of cancer. In this work, we designed a new protocol to screen for and rank the efficacy of compounds specifically targeting telomeres and telomerase. This approach used two isogenic cell lines containing a circular human artificial chromosome (HAC, lacking telomeres) and a linear HAC (containing telomeres) marked with the EGFP transgene; compounds that target telomerase or telomeres should preferentially induce loss of the linear HAC but not the circular HAC. Our assay allowed quantification of chromosome loss by routine flow cytometry. We applied this dual-HAC assay to rank a set of known and newly developed compounds, including G-quadruplex (G4) ligands. Among the latter group, two compounds, Cu-ttpy and Pt-ttpy, induced a high rate of linear HAC loss with no significant effect on the mitotic stability of a circular HAC. Analysis of the mitotic phenotypes induced by these drugs revealed an elevated rate of chromatin bridges in late mitosis and cytokinesis as well as UFB (ultrafine bridges). Chromosome loss after Pt-ttpy or Cu-ttpy treatment correlated with the induction of telomere-associated DNA damage. Overall, this platform enables identification and ranking of compounds that greatly increase chromosome mis-segregation rates as a result of telomere dysfunction and may expedite the development of new therapeutic strategies for cancer treatment. Significance: An assay provides a unique opportunity to screen thousands of chemical compounds for their ability to inactivate replication of telomeric ends in cancer cells and holds potential to lay the foundation for the discovery of new treatments for cancer. Cancer Res; 78(21); 6282–96. ©2018 AACR.